Taxus Cardium Pharmaceuticals Group (CRXM) Q3 2016 Earnings

31DecConfirmed
Mar 16
Jun 16
Nov 16
Q3 2016
-0.14
-0.1
-0.07
-0.03

Details

Expected EPS
N/A
Actual EPS
-0.0627
Surprise EPS
-0.06
Surprise Percent
+∞%

Description

Taxus Cardium Pharmaceuticals Group (CRXM) has reported earnings of -0.0627 per share for Q3 2016.

0 Comments

Share your thoughts